HUMAN GENOME SCIENCES INC Revenue
HUMAN GENOME SCIENCES INC reported Revenue of $60.34 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC revenue, net (deprecated 2018-01-31) for the quarter ending 2012-06-30 was $60.34M, a 142.75% increase year-over-year.
- HUMAN GENOME SCIENCES INC revenue, net (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $47.13M, a 77.35% increase year-over-year.
- HUMAN GENOME SCIENCES INC revenue, net (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $45.52M, a 114.09% increase year-over-year.
- HUMAN GENOME SCIENCES INC revenue, net (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $34.02M, a 33.00% decline year-over-year.
- HUMAN GENOME SCIENCES INC revenue, net (deprecated 2018-01-31) for fiscal 2011 was $130.97M, a 16.76% decline from fiscal 2010.
- HUMAN GENOME SCIENCES INC revenue, net (deprecated 2018-01-31) for fiscal 2010 was $157.35M, a 42.94% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC revenue, net (deprecated 2018-01-31) for fiscal 2009 was $275.75M.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2012-06-30 | $60.34M 10-Q · filed 2012-07-26 | $107.47M 10-Q · filed 2012-07-26 | $152.99M derived: sum of 3 quarters · filed 2012-07-26 | $187.01M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | $47.13M 10-Q · filed 2012-04-26 | $92.65M derived: sum of 2 quarters · filed 2012-04-26 | $126.67M derived: sum of 3 quarters · filed 2012-04-26 | $151.53M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $45.52M 10-K · filed 2012-02-28 | $79.54M derived: sum of 2 quarters · filed 2012-02-28 | $104.40M derived: sum of 3 quarters · filed 2012-07-26 | $130.97M 10-K · filed 2012-02-28 |
| 2011-09-30 | $34.02M 10-K · filed 2012-02-28 | $58.88M derived: sum of 2 quarters · filed 2012-07-26 | $85.45M 10-Q · filed 2011-10-28 | $106.72M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $24.86M 10-Q · filed 2012-07-26 | $51.43M 10-Q · filed 2012-07-26 | $72.69M derived: sum of 3 quarters · filed 2012-07-26 | $123.48M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | $26.57M 10-Q · filed 2012-04-26 | $47.84M derived: sum of 2 quarters · filed 2012-04-26 | $98.62M derived: sum of 3 quarters · filed 2012-04-26 | $137.41M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $21.26M 10-K · filed 2012-02-28 | $72.05M derived: sum of 2 quarters · filed 2012-02-28 | $110.84M derived: sum of 3 quarters · filed 2012-02-28 | $157.35M 10-K · filed 2012-02-28 |
| 2010-09-30 | $50.78M 10-K · filed 2012-02-28 | $89.57M derived: sum of 2 quarters · filed 2012-02-28 | $136.09M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $38.79M 10-K · filed 2012-02-28 | $85.31M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $46.51M 10-K · filed 2012-02-28 | |||
| 2009-12-31 | $275.75M 10-K · filed 2012-02-28 |